Hasil Pencarian - Rowan E. Miller

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    The role of PARP inhibitor combination therapy in ovarian cancer

    The role of PARP inhibitor combination therapy in ovarian cancer oleh Helen Hockings, Rowan E. Miller

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Disparity in the era of personalized medicine for epithelial ovarian cancer

    Disparity in the era of personalized medicine for epithelial ovarian cancer oleh Michael-John Devlin, Rowan E. Miller

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Lung carcinoma with hypertrophic osteoarthropathy in a teenager

    Lung carcinoma with hypertrophic osteoarthropathy in a teenager oleh Jeremy Whelan, Rowland O. Illing, Rowan E. Miller

    Diterbitkan 2011-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions

    Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions oleh Shanthini M Crusz, Karim El-Shakankery, Rowan E Miller

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy

    Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy oleh Georgina E. Wood, Christopher P. Bunting, Mesel Veli, Rupali Arora, Daniel M. Berney, Constantine Alifrangis, Nicola D. MacDonald, Rowan E. Miller, Rowan E. Miller, Jonathan Shamash, Sara Stoneham, Michelle Lockley, Michelle Lockley

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

    First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors oleh Rebecca Kristeleit, Juan Martin-Liberal, Kristen Spencer, Janice M Mehnert, Maria Vieito, Elizabeth J Davis, Angela Orcurto, Thomas Condamine, Daniel C Cho, Jennifer Pulini, Rowan E Miller, Sarah P Blagden, Dominik Berthold, Dana B Cardin, Prashanth Hari Dass, John E Janik, Jason Clark, Xuejun Chen

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: